These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 1429711)
1. Mutational mapping of the catalytic activities of human tyrosinase. Tripathi RK; Hearing VJ; Urabe K; Aroca P; Spritz RA J Biol Chem; 1992 Nov; 267(33):23707-12. PubMed ID: 1429711 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis. Wilczek A; Mishima Y Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677 [TBL] [Abstract][Full Text] [Related]
3. Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities. Noh H; Lee SJ; Jo HJ; Choi HW; Hong S; Kong KH J Enzyme Inhib Med Chem; 2020 Dec; 35(1):726-732. PubMed ID: 32180482 [TBL] [Abstract][Full Text] [Related]
5. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Körner A; Pawelek J Science; 1982 Sep; 217(4565):1163-5. PubMed ID: 6810464 [TBL] [Abstract][Full Text] [Related]
6. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278 [TBL] [Abstract][Full Text] [Related]
7. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. Winder AJ; Harris H Eur J Biochem; 1991 Jun; 198(2):317-26. PubMed ID: 1674912 [TBL] [Abstract][Full Text] [Related]
8. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism. Oetting WS; King RA Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241 [TBL] [Abstract][Full Text] [Related]
10. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA). Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671 [TBL] [Abstract][Full Text] [Related]
13. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the cDNA encoding human tyrosinase precursor. Takeda A; Tomita Y; Okinaga S; Tagami H; Shibahara S Biochem Biophys Res Commun; 1989 Aug; 162(3):984-90. PubMed ID: 2504160 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism. King RA; Oetting WS Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426 [TBL] [Abstract][Full Text] [Related]
16. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse. Giebel LB; Tripathi RK; King RA; Spritz RA J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309 [TBL] [Abstract][Full Text] [Related]
17. Melanin formation in the inner ear is catalyzed by a new tyrosine hydroxylase kinetically and structurally different from tyrosinase. Benedito E; Jiménez-Cervantes C; Pérez D; Cubillana JD; Solano F; Jiménez-Cervantes J; Meyer zum Gottesberge AM; Lozano JA; García-Borrón JC Biochim Biophys Acta; 1997 Jul; 1336(1):59-72. PubMed ID: 9271251 [TBL] [Abstract][Full Text] [Related]
18. Electron microscopic DOPA reaction test for oculocutaneous albinism. Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771 [TBL] [Abstract][Full Text] [Related]
19. Molecular Modeling of the Multiple-Substrate Activity of the Human Recombinant Intra-Melanosomal Domain of Tyrosinase and Its OCA1B-Related Mutant Variant P406L. Dolinska MB; Sergeev YV Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542347 [TBL] [Abstract][Full Text] [Related]
20. Assays for mammalian tyrosinase: a comparative study. Jara JR; Solano F; Lozano JA Pigment Cell Res; 1988; 1(5):332-9. PubMed ID: 2907130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]